Tianeptine, initially developed as the therapeutic compound in France , has generated considerable debate worldwide . Unlike most antidepressants which work by boosting serotonin levels, tianeptine seems to enhance serotonin transport and influences glutamate , resulting in atypical outcomes . Its accessibility through unregulated channels , often